dvt_upperlimb

upper limb DVT

introduction

  • ~10% of all cases of deep venous thrombosis (DVT) involve the upper extremity resulting in an annual incidence in USA of 0.4-1 cases per 10,000 people
  • cases have become more common with use of central venous catheters, cardiac pacemakers and defibrillators
  • compared to patients with lower limb DVT, patients with upper limb DVT are:
    • more likely to be younger and leaner
    • more likely to have underlying cancer (in a recent prospective study, 38% had cancer and 3 month mortality was 11% with only 0.5% dying from PE)
    • less likely to have underlying acquired or hereditary thrombophilia

primary upper limb DVT

  • accounts for 20% of cases

aetiology

  • venous thoracic outlet syndrome
    • DVT results from repetitive microtrauma to the subclavian vein and its surrounding structures, often due to anatomical anomalies of the costoclavicular junction.
  • Paget-Schroetter syndrome
    • 2/3rds of patients with primary upper limb DVT (mostly young men), report strenuous activity involving force (pitching a baseball, playing badminton, swimming, lifting weights, rowing, wrestling) or abduction (overhead activities such as painting, car repairs, etc) of the dominant arm prior to development of the DVT.
  • idiopathic

secondary upper limb DVT:

  • 80% of cases

aetiology

  • catheter-associated
  • cancer-associated
  • surgery or trauma of the arm or shoulder - compression or venous stasis due to immobilisation or plaster cast
  • pregnancy, OCP or ovarian hyperstimulation syndrome

clinical features

  • often subclinical - thrombosis is present in up to 2/3rds of patients with central venous catheters on routine screening without clinical signs.
  • discomfort, pain, paraesthesiae and weakness of the arm
  • swelling, oedema, discoloration and visible collaterals of the arm are typical
  • superior vena cava syndrome is usually caused by caval tumour infiltration:
    • facial swelling, headache, nausea and SOB

complications

  • pulmonary embolism (PE) is less common than in lower limb DVT - 6% vs 15-32% for lower limb DVT
    • 3 month mortality from PE
  • recurrence of DVT is less common than in lower limb DVT - 2-5% vs 10% for lower limb DVT
  • post-thrombotic syndrome is less common than in lower limb DVT - 5% vs 56% for lower limb DVT
    • risk is higher for thrombosis of the axillary subclavian veins compared with other upper limb locations
    • risk is higher with residual thrombosis at 6 months
    • risk is lower for catheter-associated thrombosis

investigation of suspected upper limb DVT

  • D-Dimer has a 100% sensitivity but given that a significant proportion of patients will have cancer or catheter, the D-Dimer is likely to be elevated anyway and specificity is very low at ~14% and thus this is NOT as useful a test as it is for pulmonary embolism (PE), and it's use is best reserved for those with low to intermediate pre-test probability in which case a negative D-Dimer is an accurate means of excluding it.
  • compression ultrasonography and duplex ultrasonography:
    • the preferred Ix but may miss proximal subclavian and brachiocephalic thromboses as these are difficult to visualise due to overlying bone.
  • CT angiography or MR angiography
    • may be useful if ultrasound is not diagnostic, and has the advantage of visualising potential associated conditions such as neoplasm, adenopathy or venous thoracic outlet anomalies.

Mx of upper limb DVT

  • removal of central venous catheter is only recommended if either:
    • no further need for it
    • no expected difficulties in gaining iv access
    • malfunction of catheter
    • infection
    • contraindication to anticoagulation
    • persisting symptoms or signs despite anticoagulation Rx
  • anticoagulation Rx:
    • usual recommendation is for initial 5 day Rx with heparin or LMW heparin1), if not contra-indicated, then re-assessment:
      • only mild symptoms ⇒ change to at least 3-6 months anticoagulation with warfarin or a LMW heparin (the latter is preferred in those with underlying cancer).
      • severe symptoms/signs, then consider:
        • catheter-directed thrombolysis if bleeding risk is low
        • catheter or surgical interventions if failure of thrombolysis and anticoagulation
  • investigation of underlying cause:
    • this should be guided based upon individual patient circumstances
    • consider thoracic CT scan
1)
NEJM 364:9 March 3 2011 p861-869
dvt_upperlimb.txt · Last modified: 2013/04/07 02:40 by 127.0.0.1

Donate Powered by PHP Valid HTML5 Valid CSS Driven by DokuWiki